9
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Propranolol Absorption in Peptic Ulcer Disease

, , &
Pages 643-646 | Received 03 Aug 1992, Accepted 08 Jan 1993, Published online: 08 Jul 2009

References

  • Routledge P A, Shand D G. Clinical pharmacokinetics of propranolol. Clin Pharmacokinet 1979; 4: 73–90
  • Kornhauser D M, Wood A JJ, Vestal R E, Wilkinson G R, Branch R A, Shand D G. Biological determinants of propranolol disposition in man. Clin Pharmacol Ther 1978; 23: 165–74
  • Gibaldi M. Gastrointestinal absorption–biologic considerations. Biopharmaceutics and clinical pharmacokinetics. 4th ed, M Gibaldi. Lea & Febiger, Philadelphia 1991; 24–40
  • Pestiaux A, Ooghe P, Van Cauter J, Henry J O, Ligny G. Comparaison du pH gastrique de 24 heures chez des temoins, des ulcereux duodenaux et des malades atteints de gastrite atrophique. Gastroenterol Clin Biol 1990; 14: 423–7
  • Lam S K, Isenberg J I, Grossman M I, Lane W H, Hogan D L. Rapid gastric emptying in duodenal ulcer patients. Dig Dis Sci 1982; 7: 598–604
  • Gubbins P O, Bertch K E. Drug absorption in gastrointestinal disease and surgery. Clin Pharmacokinet 1991; 21: 431–47
  • Calvo R, Sarabia S, Carlos R, Du Souich P. Sulfamethazine absorption and disposition: effect of surgical procedures for gastroduodenal ulcers. Biopharm Drug Dispos 1987; 8: 115–24
  • Varin F, Cubedou L X, Powell J R. Liquid chromatographic assay and disposition of carvedilol in healthy volunteers. J Pharm Sci 1986; 75: 1195–7
  • Don Brown R, Manno J E. STRIP, a basic computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 1978; 67: 1687–91
  • Mulholland M W, Debas H T. Chronic duodenal and gastric ulcer. Surg Clin North Am 1987; 67: 489–507
  • Bendtsen F, Rosenkilde-Gram B, Tage-Jensen U, Ovesen L, Rune S J. Duodenal bulb acidity in patients with duodenal ulcer. Gastroenterology 1987; 93: 1263–9
  • Kerrigan D D, Read N W, Taylor M E, Houghton L A. Duodenal bulb acidity and the natural history of duodenal ulceration. Lancet 1989; 2: 61–2
  • Donn K H, Powell J R, Rogers J F, Eshelman F N. The influence of H2 receptor antagonists on steady-state concentrations of propranolol and 4-hydroxypropranolol. J Clin Pharmacol 1984; 24: 500–8
  • Asgharnejad M, Powel J R, Donn K H, Danis M. The effect of cimetidine dose timing on oral propranolol kinetics in adults. J Clin Pharmacol 1988; 28: 339–43
  • Vestal R E, Wood A JJ, Branch R A, Shand D G, Wilkinson G R. Effect of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther 1979; 26: 8–15
  • Walle T, Walle U K, Cowart T D, Conradi E C, Gaffney T E. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolism. J Pharmacol Exp Ther 1987; 241: 928–33

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.